Total investments received (USD): 16.06m
Round value (USD): 2.46m
Round investors:
Addex Therapeutics
Company: Stalicla


Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom